These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12801889)

  • 21. Aquaporin-2 localization in clathrin-coated pits: inhibition of endocytosis by dominant-negative dynamin.
    Sun TX; Van Hoek A; Huang Y; Bouley R; McLaughlin M; Brown D
    Am J Physiol Renal Physiol; 2002 Jun; 282(6):F998-1011. PubMed ID: 11997316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A serine cluster prevents recycling of the V2 vasopressin receptor.
    Innamorati G; Sadeghi HM; Tran NT; Birnbaumer M
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2222-6. PubMed ID: 9482866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-glycosylation plays a role in biosynthesis and internalization of the adenylate cyclase stimulating vasopressin V2-receptor of LLC-PK1 renal epithelial cells: an effect of concanavalin A on binding and expression.
    Jans DA; Jans P; Luzius H; Fahrenholz F
    Arch Biochem Biophys; 1992 Apr; 294(1):64-9. PubMed ID: 1532296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alix (AIP1) is a vasopressin receptor (V2R)-interacting protein that increases lysosomal degradation of the V2R.
    Yi X; Bouley R; Lin HY; Bechoua S; Sun TX; Del Re E; Shioda T; Raychowdhury MK; Lu HA; Abou-Samra AB; Brown D; Ausiello DA
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1303-13. PubMed ID: 17287200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A role for K268 in V2R folding.
    Gouill CL; Darden T; Madziva MT; Birnbaumer M
    FEBS Lett; 2005 Sep; 579(22):4985-90. PubMed ID: 16115624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arrestin effects on internalization of vasopressin receptors.
    Bowen-Pidgeon D; Innamorati G; Sadeghi HM; Birnbaumer M
    Mol Pharmacol; 2001 Jun; 59(6):1395-401. PubMed ID: 11353798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.
    Juul KV; Bichet DG; Nielsen S; Nørgaard JP
    Am J Physiol Renal Physiol; 2014 May; 306(9):F931-40. PubMed ID: 24598801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palmitoylation of the V2 vasopressin receptor.
    Sadeghi HM; Innamorati G; Dagarag M; Birnbaumer M
    Mol Pharmacol; 1997 Jul; 52(1):21-9. PubMed ID: 9224808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agonist-independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis.
    Kocan M; See HB; Sampaio NG; Eidne KA; Feldman BJ; Pfleger KD
    Mol Endocrinol; 2009 Apr; 23(4):559-71. PubMed ID: 19179480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular and subcellular distribution of the type-2 vasopressin receptor in the kidney.
    Fenton RA; Brønd L; Nielsen S; Praetorius J
    Am J Physiol Renal Physiol; 2007 Sep; 293(3):F748-60. PubMed ID: 17553938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis.
    Erdélyi LS; Mann WA; Morris-Rosendahl DJ; Groß U; Nagel M; Várnai P; Balla A; Hunyady L
    Kidney Int; 2015 Nov; 88(5):1070-8. PubMed ID: 26131744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional variation in the arginine vasopressin 2 receptor as a modifier of human plasma von Willebrand factor levels.
    Nossent AY; Robben JH; Deen PM; Vos HL; Rosendaal FR; Doggen CJ; Hansen JL; Sheikh SP; Bertina RM; Eikenboom JC
    J Thromb Haemost; 2010 Jul; 8(7):1547-54. PubMed ID: 20403097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasopressin V2R-targeting peptide carrier mediates siRNA delivery into collecting duct cells.
    Jung HJ; Lim JS; Choi HJ; Lee MS; Kim JH; Kim SY; Kim S; Kim E; Kwon TH
    PLoS One; 2012; 7(6):e40010. PubMed ID: 22761946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of aspartate-lysine-isoleucine and aspartate-arginine-tyrosine mutations on the expression and activity of vasopressin V2 receptor gene.
    Najafzadeh H; Safaeian L; Mirmohammad Sadeghi H; Rabbani M; Jafarian A
    Iran Biomed J; 2010; 14(1-2):17-22. PubMed ID: 20683494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demonstration of the functional impact of vasopressin signaling in the thick ascending limb by a targeted transgenic rat approach.
    Mutig K; Borowski T; Boldt C; Borschewski A; Paliege A; Popova E; Bader M; Bachmann S
    Am J Physiol Renal Physiol; 2016 Aug; 311(2):F411-23. PubMed ID: 27306979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical basis of partial nephrogenic diabetes insipidus phenotypes.
    Sadeghi H; Robertson GL; Bichet DG; Innamorati G; Birnbaumer M
    Mol Endocrinol; 1997 Nov; 11(12):1806-13. PubMed ID: 9369448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of interaction of vasopressin with its antisense peptides: a functional and immunological study.
    Jurzak M; Pavo I; Fahrenholz F
    J Recept Res; 1993; 13(5):881-902. PubMed ID: 8385219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inner Ear Arginine Vasopressin-Vasopressin Receptor 2-Aquaporin 2 Signaling Pathway Is Involved in the Induction of Motion Sickness.
    Xu LH; Yang Y; Liu HX; Xiao SF; Qiu WX; Wang JX; Zhao CC; Gui YH; Liu GZ; Peng B; Li X; Wang GH; Zhou X; Jiang ZL
    J Pharmacol Exp Ther; 2020 May; 373(2):248-260. PubMed ID: 32165443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.
    Postina R; Kojro E; Fahrenholz F
    Adv Exp Med Biol; 1998; 449():371-85. PubMed ID: 10026828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations of Vasopressin Receptor 2 Including Novel L312S Have Differential Effects on Trafficking.
    Tiulpakov A; White CW; Abhayawardana RS; See HB; Chan AS; Seeber RM; Heng JI; Dedov I; Pavlos NJ; Pfleger KD
    Mol Endocrinol; 2016 Aug; 30(8):889-904. PubMed ID: 27355191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.